Inhibition of P-Selectin and PSGL-1 using humanized monoclonal antibodies increases the sensitivity of multiple myeloma cells to bortezomib

Authors

Barbara Muz, Washington University School of Medicine in St. Louis
Feda Azab, Washington University School of Medicine in St. Louis
Pilar de la Puente, Washington University School of Medicine in St. Louis
Scott Rollins, Selexys Pharmaceuticals
Richard Alvarez, Selexys Pharmaceuticals
Ziad Kawar, Selexys Pharmaceuticals
Abdel Kareem Azab, Washington University School of Medicine in St. Louis

Journal

BioMed Research International

Publication Date

2015

Volume

2015

Issue

417586

Inclusive Pages

1-8

Document Type

Open Access Publication

DOI

10.1155/2015/417586

Rights and Permissions

Barbara Muz, Feda Azab, Pilar de la Puente, et al., “Inhibition of P-Selectin and PSGL-1 Using Humanized Monoclonal Antibodies Increases the Sensitivity of Multiple Myeloma Cells to Bortezomib,” BioMed Research International, vol. 2015, Article ID 417586, 8 pages, 2015. doi:10.1155/2015/417586

Recommended Citation

Muz, Barbara; Azab, Feda; Puente, Pilar de la; Rollins, Scott; Alvarez, Richard; Kawar, Ziad; and Azab, Abdel Kareem, "Inhibition of P-Selectin and PSGL-1 using humanized monoclonal antibodies increases the sensitivity of multiple myeloma cells to bortezomib." BioMed Research International. 2015, 417586. 1-8. (2015).
https://digitalcommons.wustl.edu/open_access_pubs/4421